Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies AH Bio Fund IV, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- Erez Chimovits - $34.92M in BRVE purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $34.92M in BRVE purchases and sales in the last 12 months
- Christopher Viehbacher - $1.50M in BRVE purchases and sales in the last 12 months
- Travis Murdoch - $1.50M in BRVE purchases and sales in the last 12 months
- David Charles Lubner - $1000K in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is AH Bio Fund IV, L.P.?
AH Bio Fund IV, L.P. is an investment firm, tracked as 10% Owner of Braveheart Bio, Inc. (BRVE). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has AH Bio Fund IV, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has AH Bio Fund IV, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($19.80M) and 0 open-market sales across all tracked filings.
